Moderna (NASDAQ:) shares closed decrease on Tuesday after the vaccine maker mentioned that its vaccine towards seasonal flu didn't obtain “early success” within the Part 3 trial. Following yesterday’s selloff, Moderna shares are...
by Michael
Did you know that we are in the middle of the worst bird flu outbreak ever recorded? Millions upon millions of birds have been dying, and most people don’t even realize that...
